Incidence and prevalence of antiphospholipid syndrome (APS) in the USA (2016–2019): a retrospective database study
These data add to the estimates of prevalence and incidence of APS in the literature, all of which have different strengths and limitations of the different data sources and case ascertainment methods.
Authors
- Piotr Zaremba
- Anna Scowcroft (ORCID: https://orcid.org/0000-0002-4727-9243)
- Adam Jędrzejczyk
- Meheni Khellaf (ORCID: https://orcid.org/0000-0002-6449-5917)
- Maria Sarno
- Paul Meisner
Institutions
- Blue Planet (Norway) (NO)
- UCB Pharma (United Kingdom) (GB)
- North Carolina Clinical Research (US)
- Diagnostics for the Real World (United Kingdom) (GB)
- Diagnostics for the Real World (United States) (US)
- UCB Pharma (Belgium) (BE)
Publication Details
- Journal
- BMJ Open
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1136/bmjopen-2024-084563
- Citations
- 1
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.47
Funders
- UCB Pharma